<DOC>
	<DOC>NCT00170274</DOC>
	<brief_summary>The goal of APART is the assessment of the therapeutic and preventive stimulation algorithms of the Medtronic AT500 and following devices in patients with atrial tachyarrhythmias and an indication for cardiac pacing according to the German guidelines. Medication is controlled throughout the study with a beta-blocker as the only antiarrhythmic drug.</brief_summary>
	<brief_title>APART: Prevention and Automatic Therapy of Atrial Arrhythmias in Patients With Paroxysmal Supraventricular Tachycardias</brief_title>
	<detailed_description />
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Tachycardia, Supraventricular</mesh_term>
	<criteria>Indication for cardiac pacing according to the German guidelines Documented (electrocardiogram; ECG) atrial arrhythmia during the last three months before enrollment Willingness to terminate antiarrhythmic drugs until the first recurrence of an atrial arrhythmia Sinus rhythm during 24 hours before implant of the device Ejection fraction below 40% Mechanic prosthesis of the tricuspid valve Indication to implantable cardioverter defibrillator (ICD)implantation Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Indication for cardiac pacing</keyword>
	<keyword>Atrial Arrhythmia</keyword>
	<keyword>Indication for the implantation of a pacemaker according to the German guidelines</keyword>
	<keyword>Documented (ECG) atrial tachyarrhythmia within the last three months before enrollment</keyword>
</DOC>